Bristol-Myers Shells Out $21M To Settle Orencia Suit

Bristol-Myers Squibb Co. has agreed to pay $21 million to drug developer ZymoGenetics Inc. to settle a patent lawsuit over Bristol Myers' rheumatoid arthritis drug Orencia, both companies said in regulatory filings Thursday.

Kraft Settles Coffee Pod Patent Suit For $17M

Kraft Foods Global Inc. has agreed to pay $17 million to settle a patent lawsuit with Green Mountain Coffee Roasters Inc. subsidiary Keurig Inc. over single-serving coffee pods.